b 555 872 (Medroxyprogesterone 2.5 mg)
Pill imprint b 555 872 has been identified as Medroxyprogesterone acetate 2.5 mg.
Medroxyprogesterone is used in the treatment of abnormal uterine bleeding; amenorrhea; endometrial hyperplasia, prophylaxis; birth control; endometrial cancer (and more), and belongs to the drug classes contraceptives, hormones/antineoplastics, progestins. Not for use in pregnancy. Medroxyprogesterone 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- b 555 872
- 2.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
methylcellulose (15 mPa.s)
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|66267-0141||Nucare Pharmaceuticals Inc (repackager)|
|55887-0291||Diversified Healthcare Services Inc (repackager)|
|66336-0213||Dispensing Solutions Inc. (repackager)|
|23490-5855||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about medroxyprogesterone
- Medroxyprogesterone injectable suspension
- Medroxyprogesterone injectable suspension (subcutaneous)
- Medroxyprogesterone injection
- Medroxyprogesterone (Advanced Reading)
- Medroxyprogesterone Intramuscular (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.